Anthropic Shares Are Tumbling, Here’s What NYU’s “Dean Of Valuation” Says It’s Really Worth
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Anthropic (NASDAQ:ANT) is giving back more of its debut gains on its second day as a public company. In premarket trading as of 9:10 a.m. ET, shares changed hands at $88.38, down 9.05% from Thursday’s close of $97.17. The stock still sits above the $83 IPO price Anthropic set, but well below its $111.50 opening trade and $115.10 intraday high from day one.
Reuters called the pullback a reality check for the AI trade. One of the most closely followed voices in valuation reached a cooler conclusion before the first trade even happened.
Why Investors Pay Attention to Damodaran
Aswath Damodaran has taught corporate finance and valuation at NYU’s Stern School of Business since 1986. He posts his spreadsheets, data sets and reasoning on his NYU Stern home page and his blog, Musings on Markets, so anyone can rerun his math with different inputs. That transparency is why his numbers circulate widely when a major company goes public.
Damodaran’s $76 Value Sits Below the Offering Price
Aswath Damodaran estimates Anthropic’s value at $76 per share, which compares with the $83 IPO price Anthropic set. His figure falls below the offering price itself. By his math, investors who received shares at the IPO paid more than intrinsic value before any first-day pop, and anyone buying at Thursday’s close paid a wider premium still.
What Pushed His Estimate Lower
Damodaran’s first pass, published November 2, 2026, put Anthropic’s equity at $1.475 trillion but used a placeholder share count. In his updated post, he wrote that the amended prospectus added third-quarter numbers and that the midterm elections may make data centers “more difficult and expensive to build” while AI regulation could become more stringent. He trimmed his value as a result.
His method is a discounted cash flow model, which estimates the cash a business will generate in the future and converts it to today’s dollars after adjusting for time and risk. Four inputs do most of the work:
- Revenue growth: The S-1 shows revenue of $16,286 million for the six months ended June 30, 2026, up 1,300%, though the company warns its growth rate will decline.
- Reinvestment: He cut the revenue Anthropic generates per dollar of capital invested in the first five years from $3 to $2.75, which raises the spending needed to fund growth.
- Operating margin: This is the share of revenue left after operating costs. He lowered his long-run margin assumption and modeled more regulatory drag. Computing ate 55% of revenue in the first half.
- Share count: He flagged dilution from stock-based compensation and Anthropic’s multiple share classes.
Why the Market Paid More
Demand ran hot. Anthropic priced above its $70.00 to $78.00 range from the November 10 SEC filing and raised $81 billion, the largest offering on record. Buyers above $76 are effectively assuming faster growth, fatter margins or lighter capital needs than Damodaran models. Bulls can point to adjusted net income of $2,671 million in the first half and deep supplier ties: NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) said it “expanded Anthropic’s access to NVIDIA Grace Blackwell and Vera Rubin capacity”. The counterweight is roughly $265.6 billion in guaranteed computing commitments as of June 30. All of that compute has to be powered and cooled by someone, and we rounded up seven infrastructure names behind the AI buildout in a free report.
What to Watch Next
- Fiscal 2026 results: The first annual report will show how hard compute costs are pressing on margins, the input Damodaran cut.
- Lockup releases: Insiders agreed to a lockup of up to 180 days, with releases spread across that period. One release lands on the second full Nasdaq trading day after fiscal 2026 results are published.
- Revenue growth trend: Each disclosure will test whether growth slows as gradually as the S-1 warns or faster.
- Damodaran’s next update: He revises valuations as new filings arrive, and his $76 figure is a useful marker to compare against the share price.
For a long-term investor, the gap between the share price and Damodaran’s estimate shows how much optimism is already priced in. Tracking margins and reinvestment over the next few reports will show which side’s assumptions hold up.
Contact [email protected] for any questions or corrections.







